公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2011 | Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: Findings from the Breast Cancer Association Consortium | Broeks A.; Schmidt M.K.; Sherman M.E.; Couch F.J.; Hopper J.L.; Dite G.S.; Apicella C.; Smith L.D.; Hammet F.; Southey M.C.; Van't Veer L.J.; De Groot R.; Smit V.T.H.B.M.; Fasching P.A.; Beckmann M.W.; Jud S.; Ekici A.B.; Hartmann A.; Hein A.; Schulz-Wendtland R.; Burwinkel B.; Marme F.; Schneeweiss A.; Sinn H.-P.; Sohn C.; Tchatchou S.; Bojesen S.E.; Nordestgaard B.G.; Flyger H.; ?rsted D.D.; Kaur-Knudsen D.; Milne R.L.; P?rez J.I.A.; Zamora P.; Rodr?guez P.M.; Ben?tez J.; Brauch H.; Justenhoven C.; Ko Y.-D.; Network T.G.; Hamann U.; Fischer H.-P.; Br?ning T.; Pesch B.; Chang-Claude J.; Wang-Gohrke S.; Bremer M.; Karstens J.H.; Hillemanns P.; D?rk T.; Nevanlinna H.A.; Heikkinen T.; Heikkil? P.; Blomqvist C.; Aittom?ki K.; Aaltonen K.; Lindblom A.; Margolin S.; Mannermaa A.; Kosma V.-M.; Kauppinen J.M.; Kataja V.; Auvinen P.; Eskelinen M.; Soini Y.; Chenevix-Trench G.; Spurdle A.B.; Beesley J.; Chen X.; Holland H.; Lambrechts D.; Claes B.; Vandorpe T.; Neven P.; Wildiers H.; Flesch-Janys D.; Hein R.; L?ning T.; Kosel M.; Fredericksen Z.S.; Wang X.; Giles G.G.; Baglietto L.; Severi G.; McLean C.; Haiman C.A.; Henderson B.E.; Le Marchand L.; Kolonel L.N.; Aln?s G.G.; Kristensen V.; B?rresen-Dale A.-L.; Hunter D.J.; Hankinson S.E.; Andrulis I.L.; Mulligan A.M.; O'Malley F.P.; Devilee P.; Huijts P.E.A.; Tollenaar R.A.E.M.; Van Asperen C.J.; Seynaeve C.S.; Chanock S.J.; Lissowska J.; Brinton L.; Peplonska B.; Figueroa J.; Yang X.R.; Hooning M.J.; Hollestelle A.; Oldenburg R.A.; Jager A.; Kriege M.; Ozturk B.; Van Leenders G.J.L.H.; Hall P.; Czene K.; Humphreys K.; Liu J.; Cox A.; Connley D.; Cramp H.E.; Cross S.S.; Balasubramanian S.P.; Reed M.W.R.; Dunning A.M.; Easton D.F.; Humphreys M.K.; Caldas C.; Blows F.; Driver K.; Provenzano E.; Lubinski J.; Jakubowska A.; Huzarski T.; Byrski T.; Cybulski C.; Gorski B.; Gronwald J.; Brennan P.; Sangrajrang S.; Gaborieau V.; Shen C.-Y.; Hsiung C.-N.; Yu J.-C.; Chen S.-T.; Hsu G.-C.; Hou M.-F.; CHIUN-SHENG HUANG ; Anton-Culver H.; Ziogas A.; Pharoah P.D.P.; Garcia-Closas M.; kConFab51, AOCS50,51 | Human Molecular Genetics | 148 | 139 | |
2014 | MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis | Chan S.-H.; Huang W.-C.; Chang J.-W.; KING-JEN CHANG ; WEN-HUNG KUO ; Wang M.-Y.; Lin K.-Y.; Uen Y.-H.; Hou M.-F.; Lin C.-M.; Jang T.-H.; Tu C.-W.; Lee Y.-R.; Lee Y.-H.; Tien M.-T.; Wang L.-H. | Oncogene | 120 | 113 | |
2020 | Neratinib plus capecitabine versus lapatinib plus capecitabine in HER2-positive metastatic breast cancer previously treated with ? 2 HER2-directed regimens: Phase III NALA trial | Saura C.; Oliveira M.; Feng Y.-H.; Dai M.-S.; Chen S.-W.; Hurvitz S.A.; Kim S.-B.; Moy B.; Delaloge S.; Gradishar W.; Masuda N.; Palacova M.; Trudeau M.E.; Mattson J.; Yap Y.S.; Hou M.-F.; De Laurentiis M.; Yeh Y.-M.; Chang H.-T.; Yau T.; Wildiers H.; Haley B.; Fagnani D.; YEN-SHEN LU ; Crown J.; Lin J.; Takahashi M.; Takano T.; Yamaguchi M.; Fujii T.; Yao B.; Bebchuk J.; Keyvanjah K.; Bryce R.; Brufsky A.; NALA Investigators | Journal of Clinical Oncology | 360 | 311 | |
2016 | Pegylated Liposomal Doxorubicin as Adjuvant Therapy for Stage I-III Operable Breast Cancer | Lu Y.-C.; Ou-Yang F.U.; Hsieh C.-M.; KING-JEN CHANG ; Chen D.-R.; Tu C.-W.; Wang H.-C.; Hou M.-F. | In vivo (Athens, Greece) | 7 | 0 | |
2014 | Predictive factors of overall quality of life in advanced cancer patients using EORTC QLQ-C30 | Cramarossa G.; Zeng L.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; Alm El-Din M.A.; Kumar A.; Forges F.; WEI-CHU CHIE ; Sahgal A.; Lam H.; Pulenzas N.; Chow E. | Expert Review of Pharmacoeconomics and Outcomes Research | 7 | 7 | |
2013 | Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30 | Lam K.; Zeng L.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; El-Din M.A.A.; Kumar A.; Pharmd F.F.; WEI-CHU CHIE ; Sahgal A.; Poon M.; Chow E. | Journal of Palliative Medicine | 11 | 10 | |
2012 | Quality of life after palliative radiation therapy for patients with painful bone metastases: Results of an international study validating the EORTC QLQ-BM22 | Zeng L.; Chow E.; Bedard G.; Zhang L.; Fairchild A.; Vassiliou V.; Alm El-Din M.A.; Jesus-Garcia R.; Kumar A.; Forges F.; Tseng L.-M.; Hou M.-F.; WEI-CHU CHIE ; Bottomley A. | International Journal of Radiation Oncology Biology Physics | 80 | 68 | |
2013 | Quality of life assessment in Taiwanese patients with bone metastases from breast cancer receiving zoledronic acid | Chao T.-C.; Chen D.-R.; Chao T.-Y.; Chen S.-C.; Yeh D.-C.; Wang H.-C.; Huang W.-T.; Rau K.-M.; KING-JEN CHANG ; Yang T.-L.; Lee K.-D.; Tai C.-J.; Tseng L.-M.; Hou M.-F. | Anticancer Research | 1 | ||
2016 | Symptom clusters analysis in bone metastases patients | Chiu L.; Chow E.; Chiu N.; Zhang L.; Bedard G.; Fairchild A.; Vassiliou V.; El-Din M.A.A.; Jesus-Garcia R.; Forges F.; Tseng L.-M.; Hou M.-F.; WEI-CHU CHIE ; Satoh T.; Ma B.B.; Lam H.; Bottomley A. | Cancer: Pain and Symptom Management | 0 | ||
2013 | Symptom clusters analysis in bone metastases patients using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Bone Metastases Module (EORTC QLQ-BM22) | Chiu L.; Chow E.; Chiu N.; Zhang L.; Bedard G.; Fairchild A.; Vassiliou V.; El-Din M.A.A.; Jesus-Garcia R.; Forges F.; Tseng L.-M.; Hou M.-F.; WEI-CHU CHIE ; Satoh T.; Ma B.B.Y.; Lam H.; Bottomley A. | Journal of Pain Management | 0 | ||
2018 | Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7–CYFIP1-mediated signaling pathway | Chang J.-W.; WEN-HUNG KUO ; Lin C.-M.; Chen W.-L.; Chan S.-H.; Chiu M.-F.; Chang I.-S.; Jiang S.-S.; Tsai F.-Y.; Chen C.-H.; PEI-HSIN HUANG ; KING-JEN CHANG ; Lin K.-T.; Lin S.-C.; Wang M.-Y.; Uen Y.-H.; Tu C.-W.; Hou M.-F.; Tsai S.-F.; Shen C.-Y.; Tung S.-L.; Wang L.-H. | Oncogene | 33 | 32 |